
In the trial, carried out in 108 healthy adults, the vaccine demonstrated promising results after 28 days, with the final results to be evaluated in six months, the study said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ggKtbu
via
IFTTT
0 comments:
Post a Comment